GP Helios by Geneza Pharmaceuticals is the injectable thermogenic on this page, offered here at Best Anabolic Steroids. The vial carries two sympathomimetic molecules in oil at a fixed ratio, clenbuterol and yohimbine, and it is a fat-loss tool rather than an anabolic one.
Everything below is reference material taken from published pharmacology and from the source sheet behind this blend. It describes dosage shapes, timing and the warning signs that stop a block, and it is not a prescription or a treatment plan for any condition.
Product Overview
The two compounds work from opposite ends of the same system. Clenbuterol is a beta-2 adrenergic agonist: it raises metabolic rate and temperature, which is where its fat-loss reputation comes from. Yohimbine is an alpha-2 adrenergic antagonist, blocking the receptor that brakes fat release, and it is included to add a second angle on mobilising stored fat rather than to add raw stimulation.
Neither molecule is a steroid. The blend does not aromatise, it holds no water, and it does not suppress the hypothalamic-pituitary-gonadal axis, so the recovery drugs used after an anabolic cycle have no place here. It is also a blend rather than two separate products: the ratio of clenbuterol to yohimbine is fixed in the oil, and a user cannot adjust one without the other.
The single most important property is how long clenbuterol stays active - a day or two per dose - against the roughly two-week adaptation of the beta-2 receptor. That mismatch is the reason the blend is run in short blocks with a break rather than continuously. For the oral version of the same stimulant, the source sheet behind Clenbuterol covers it, and T3 Liothyronine is the thyroid-side option often read alongside a thermogenic.
Dosage Protocol
No approved dose exists for this blend. The rows below are the ranges the sources give for the two components, kept separate because the vial fixes one ratio and the sensitivities differ.
| Beginner | Start at 20-40 mcg of clenbuterol with 5-10 mg of yohimbine per day, stepping up every couple of days as tolerance allows |
| Intermediate | 40-80 mcg of clenbuterol with 10-15 mg of yohimbine per day, spread over two or three separate blocks |
| Advanced | Clenbuterol 80-120 mcg per day with yohimbine no higher than 0.2 mg per kilogram, and six to eight weeks as the overall intake ceiling |
| Female | A 20-40 mcg clenbuterol ceiling with 5-10 mg of yohimbine, run in the same fortnightly blocks; the sources offer no validated female schedule |
| Administration | Oral or intramuscular; two weeks of use followed by two weeks off, since the beta-2 receptor adapts over roughly that period |
Two rules sit above the numbers. Start low and go up slowly, because the first days set whether the user can tolerate the tremor and the heart rate. And never add caffeine, ephedrine or another beta-agonist on top: the three stacks the same stimulation and multiplies the strain on the heart rather than the result.
Suggested Protocols
Helios belongs to a cutting phase as a thermogenic layer on top of diet and cardio, not as a replacement for them.
Users who react badly to clenbuterol sometimes look at a non-stimulant route instead. Proviron is added in some cutting plans for androgen support, and a dry compound such as Methenolone Enanthate carries a lean profile without touching heart rate.
What to Expect
- Warmer and sweatier in the first days. A raised body temperature and more perspiration are the usual early signs that the beta-2 arm is doing something.
- More capacity to work. Stimulation and a lift in output show up quickly and feel close to an ephedrine-type effect, which is why the dose is titrated rather than set high at the start.
- Weight loss is calorie-driven. The blend raises expenditure; it does not burn fat on its own, and it does nothing at all if the diet does not create a deficit.
- No muscle-building claim holds. The anabolic effect claimed for clenbuterol in animals has not been confirmed in humans.
- Tremor and a racing pulse are common. Both are dose-dependent, and both are the signal to hold or lower the dose rather than push through.
- The response fades by the second week. That adaptation, not the drug, is the reason for the two-week block and the break that follows it.
Side Effects and Management
Everything worth watching here is cardiovascular or stimulant-driven, so the people at risk are those with heart or blood pressure problems in the first place.
After the Block
The usual post-cycle sections do not apply here, and the reason is worth stating plainly rather than leaving a row empty.
Storing the Vial
An oil-based injectable is comfortable at room temperature in a dry cupboard, upright and out of the light, and the cap closed between draws. Cold storage gains nothing and can thicken the oil; condensation around the stopper is the risk that comes with it.
Warm the vial in the hand for a moment before a draw to thin the solution, and use a fresh needle for the injection itself. Check the label and the batch on arrival, and keep the container away from children and away from any other stimulant product in the house, because a mis-drawn dose of clenbuterol is not a small mistake.
For the thermogenic route without clenbuterol, Turinabol is an oral that keeps a lean, dry profile inside a cutting block without touching heart rate or temperature.
